SCHEMBL30193288

SCHEMBL30193288

CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 10/20 0.64
CTSK P43235 9/20 0.64
CTSB P07858 4/20 0.64
CTSL P07711 2/20 0.64
BCL2 P10415 1/20 0.61
AKT1 P31749 1/20 0.56
ACE P12821 1/20 0.56
HDAC8 Q9BY41 1/20 0.53
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
PKM P14618 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
XBP1 P17861 1/20 0.52
HTT P42858 1/20 0.52
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11979695 0.89 CTSS (0.63) CTSSCTSKCTSBCTSLBCL2
SCHEMBL1164315 0.89 CTSS (0.63) CTSSCTSKCTSBCTSLBCL2
SCHEMBL17624777 0.89 CTSS (0.55) CTSSCTSKCTSBCTSLBCL2
SCHEMBL8000628 0.87 CTSS (0.65) CTSSCTSKCTSBCTSLBCL2
SCHEMBL8611600 0.86 BCL2 (0.76) CTSSCTSKCTSBCTSLBCL2
SCHEMBL7709249 0.85 CA2 (0.56) CTSSCTSKCTSBCTSLBCL2
SCHEMBL6494733 0.83 CA1 (0.67) CTSSCTSKCTSBCTSLAKT1
SCHEMBL6163823 0.82 CTSS (0.73) CTSSCTSKCTSBCTSLAKT1
SCHEMBL8951298 0.82 CTSS (0.73) CTSSCTSKCTSBCTSLAKT1
SCHEMBL6163323 0.82 CTSS (0.73) CTSSCTSKCTSBCTSLAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265173-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES ZYMEWORKS BC INC. (CA) 2023-08-24 US disclosed
US-11560422-B2 Sulfonamide-containing linkage systems for drug conjugates ZYMEWORKS INC. 2023-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265173-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES MPST, TPST2, SULT1A1 CTSS 877/4885CTSK 2901/4885CTSB 2251/4885
US-11560422-B2 Sulfonamide-containing linkage systems for drug conjugates MPST, TPST2, SULT1A1 CTSS 877/4885CTSK 2901/4885CTSB 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.